Search Our Website:

Ed Allera and Barbara Binzak Blumenfeld, Shareholders in the firm's FDA & Biotechnology section, were included as experts to weigh in on the potential affects of China's tariffs on the medtech and healthcare industry in Becker's Spine Review's article "How Will Proposed Trump, China Tariffs Affect Medtech and Healthcare? 5 Key Thoughts."